EffectoframosetrononQTcinterval:arandomisedcontrolledtrialinpatientsundergoingoff-pumpcoronaryarterybypasssurgery
AbstractBackgroundRamosetronisarelativelynew5-hydroxytryptaminethreereceptorantagonistwithhigherbindingaffinityandmoreprolongeddurationofaction